Form 4 for GH Guardant Health, Inc.
Accepted 2026-09-14 18:12:29 ET · period of report 2026-09-12 · accession 0001402256-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-14 18:12 | 2026-09-12 | GH | Azar Alex M II | Dir | M - OptEx | $0.00 | +1,651 | 1,651 | New | $0 |
| D | 2026-09-14 18:12 | 2026-09-12 | GH | Azar Alex M II | Dir | M - OptEx | $0.00 | -1,651 | 4,953 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-12 | M | A | 1,651 | $0.00 | 1,651 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2026-09-12 | M | D | 1,651 | $0.00 | 4,953 | D | $0.00 · — to — | 1,651 Common Stock | (F1) The restricted stock unit award was granted on September 12, 2025 and vests over a four-year period. 25% of the shares subject to such award vested on September 12, 2026 and the remaining 75% vests monthly for the three-year period thereafter. (F2) Not applicable for Restricted Stock Units. |